Ideaya Biosciences Inc

+0.21 (+1.18%)
6:05:29 PM EDT: $17.98 0.00 (0.00%)
Earnings Announcements

Ideaya Biosciences Reports Third Quarter Financial Results

Published: 11/08/2022 12:13 GMT
Ideaya Biosciences Inc (IDYA) - Ideaya Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update.
Ideaya Biosciences - $393.9 Million Cash, Cash Equivalents & Marketable Securities As of Sept 30, is Anticipated to Fund Planned Operations Into 2026.
Ideaya Biosciences Inc - Qtrly Basic Earnings per Share $0.04.
Revenue is expected to be $6.5 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $5.87 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.